Skip to content
MedsAcross

Medicine

Syndros 5 mg/mL oral solution

Dronabinol · Oral · Wellhouse Pharma
Available on requestPrescription onlyUS FDA Cold chainControlled, schedule CII

Syndros 5 mg/mL oral solution is a prescription medicine containing Dronabinol for oral use, marketed by Wellhouse Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store in a refrigerator between 2°C and 8°C (36°F and 46°F), excursions…

Key facts

Active ingredient (INN)
Dronabinol
Brand
Syndros
Strength
5 mg/mL
Dosage form
Oral solution
Route
Oral
Packs
1 bottle
Marketing authorisation holder
Wellhouse Pharma
Manufacturers
Wellhouse PharmaBenuvia Operations
Origin register
US FDA, United States
Storage
Store in a refrigerator between 2°C and 8°C (36°F and 46°F), excursions permitted up to 25°C (77°F). The opened bottle can be stored at 25°C (77°F).
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Schedule CII
ATC code
A04AD10 Dronabinol
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 July 2017
Identifiers
RxCUI 1928948, 1928954DailyMed set ID a7801c70-995d-46a2-91ee-141ef427c6b5, 3cdcb4f5-5af9-4ff7-b535-2a5cf4c6da89NDC 78613-201, 85776-201Application NDA205525

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 bottle, glass in 1 carton / 30 mL in 1 bottle, glass85776-201-30Wellhouse Pharma16 April 2026
1 bottle, glass in 1 carton / 30 mL in 1 bottle, glass78613-201-30Benuvia Operations1 July 2017

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 31 May 1985Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Dronabinol 5 mg/mL oral solution.

Compare 1

Other strengths and forms of Dronabinol

Clinical summary

Dronabinol is a cannabinoid indicated in adults for the treatment of anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS). It is available as capsules and oral solution. MedsAcross supplies Dronabinol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Dronabinol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Syndros 5 mg/mL oral solution for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.